CD19 Human Monoclonal Antibody
Anti-Human CD19 (BPMZ231) is a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4
UniProt
P15391
Reactivity
Human
Clonality
Monoclonal
Clone
BPMZ231
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![11,11'-(2,2'-(Piperazine-1,4-diyl)bis(acetyl))bis(5H-benzo[e]pyrido[3,2-b][1,4]diazepin-6(11H)-one)-d8](https://cdn.genprice.uk/products/572/1806382576758/imageurl/trc-p480147-1mg.webp)
11,11'-(2,2'-(Piperazine-1,4-diyl)bis(acetyl))bis(5H-benzo[e]pyrido[3,2-b][1,4]diazepin-6(11H)-one)-d8
